October 29, 2012 / 6:31 AM / 5 years ago

Ipsen lifts outlook as Q3 sales rise 5 pct

PARIS, Oct 29 (Reuters) - French drugmaker Ipsen raised its outlook for 2012 as it reported a 5 percent increase in third-quarter revenue, driven by sales of drugs prescribed by specialist doctors.

Sales rose to 295 million euros ($382 million) in the three months to Sept. 30 from 281 million a year earlier, Ipsen said on Monday. ($1 = 0.7733 euros) (Reporting by Elena Berton)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below